Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Cymabay Therapeutics (CBAY)

3.85   -0.04 (-1.03%) 06-04 16:00
Open: 3.87 Pre. Close: 3.89
High: 4 Low: 3.83
Volume: 1,130,896 Market Cap: 265M
CymaBay Therapeutics Inc is an American biotechnology enterprise. Its product candidates include Arhalofenate, MBX-8025, and MBX-2982, which are meant to combat serious metabolic diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.002 - 4.029 4.029 - 4.051
Low: 3.779 - 3.805 3.805 - 3.826
Close: 3.812 - 3.854 3.854 - 3.889

Technical analysis

as of: 2020-06-04 4:29:31 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 5.78     One year: 6.75
Support: Support1: 2.88    Support2: 1.60
Resistance: Resistance1: 4.95    Resistance2: 5.78
Pivot: 3.93
Moving Average: MA(5): 3.83     MA(20): 3.64
MA(100): 2.05     MA(250): 3.81
MACD: MACD(12,26): 0.45     Signal(9): 0.51
Stochastic oscillator: %K(14,3): 34.12     %D(3): 43.01
RSI: RSI(14): 64.97
52-week: High: 12.10  Low: 1.21  Change(%): -66.6
Average Vol(K): 3-Month: 349804  10-Days: 171928

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
CBAY has closed above bottom band by 31.3%. Bollinger Bands are 53.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to CBAY's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 12 May 2020
CymaBay Therapeutics Inc (CBAY) Q1 2020 Earnings Call Transcript - The Motley Fool

Wed, 13 May 2020
Do Options Traders Know Something About CymaBay Therapeutics (CBAY) Stock We Don't? - Yahoo Finance

Fri, 15 May 2020
Is CymaBay Therapeutics (CBAY) Stock a Solid Choice Right Now? - Nasdaq

Tue, 02 Jun 2020
The Zacks Analyst Blog Highlights: Aileron Therapeutics, Energy Focus, MicroVision, Mersana Therapeutics and CymaBay Therapeutics - Yahoo Finance

Wed, 13 May 2020
CymaBay (CBAY) Stock Is up 127% in a Day. How Much Higher Can It Go? - Yahoo Finance

Mon, 01 Jun 2020
Market Analysts see CymaBay Therapeutics Inc. [CBAY] gaining to $9. Time to buy? - The DBT News

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 69
Shares Float (M) 59
% Held by Insiders 0.62
% Held by Institutions 88.01
Shares Short (K) 7,860
Shares Short P. Month (K) 8,540

Stock Financials

EPS -1.350
EPS Est This Year -0.820
EPS Est Next Year -0.740
Book Value (p.s.) 2.540
Profit Margin
Operating Margin
Return on Assets (ttm) -25.0
Return on Equity (ttm) -42.9
Qtrly Rev. Growth
Gross Profit (p.s.) -0.938
Sales Per Share
EBITDA (p.s.) -1.337
Qtrly Earnings Growth
Operating Cash Flow (M) -90
Levered Free Cash Flow (M) -54

Stock Valuations

PE Ratio -2.85
PEG Ratio
Price to Book value 1.52
Price to Sales
Price to Cash Flow -2.94

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.